Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status

Even in the era of combination antiretroviral therapies used to combat human immunodeficiency virus type 1 (HIV-1) infection, up to 50% of well-suppressed HIV-1-infected patients are still diagnosed with mild neurological deficits referred to as HIV-associated neurocognitive disorders (HAND). The mu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurovirol
Main Authors: Dampier, Will, Antell, Gregory C., Aiamkitsumrit, Benjamas, Nonnemacher, Michael R., Jacobson, Jeffrey M., Pirrone, Vanessa, Zhong, Wen, Kercher, Katherine, Passic, Shendra, Williams, Jean W., James, Tony, Devlin, Kathryn N., Giovannetti, Tania, Libon, David J., Szep, Zsofia, Ehrlich, Garth D., Wigdahl, Brian, Krebs, Fred C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226925/
https://ncbi.nlm.nih.gov/pubmed/27400931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13365-016-0462-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados